Legal
Effective Date: February 4, 2026
Company: MYOUSS Group LLC, operating as HHAOps
Please read these Terms of Service carefully before accessing or using the HHAOps platform. These Terms constitute a legally binding agreement between MYOUSS Group LLC, operating as HHAOps (“we,” “us,” or “HHAOps”), and the home healthcare agency that has executed an order or subscription agreement with us (“Agency” or “you”). By accessing the platform, you represent that you have the authority to bind your Agency to these Terms.
"Agency" means the home healthcare agency that has subscribed to the platform and is the contracting customer.
"User" means any individual authorized by the Agency to access the platform under the Agency's account, including coordinators, administrators, and other agency staff.
"Platform" means the HHAOps SaaS application, tools, APIs, and related services provided at HHAOps.com.
"PHI" means Protected Health Information as defined under HIPAA.
"BAA" means the Business Associate Agreement executed between the Agency and MYOUSS Group LLC governing the handling of PHI.
"Subscription" means the Agency's access to the Platform as described in the applicable Order Form.
"Order Form" means the commercial agreement executed between the Agency and MYOUSS Group LLC specifying pricing, authorized user counts, billing cadence, term dates, and any custom terms applicable to that Agency.
The Agency is responsible for all activity on its account, including all actions taken by its Users. The Agency shall ensure that: (a) all Users are authorized employees or contractors of the Agency; (b) User credentials are kept confidential and not shared; (c) the Agency promptly notifies us of any unauthorized access or security incident; and (d) the Agency's use of the platform complies with all applicable laws, including HIPAA.
The number of Users authorized to access the Platform under an Agency's Subscription is set forth in the applicable Order Form. The Agency may not permit access by more Users than authorized. Changes to the number of authorized Users, or to the pricing model, are agreed upon through a revised or supplemental Order Form.
The Agency must provide accurate and complete information during registration and keep such information current. We reserve the right to suspend or terminate accounts where inaccurate or fraudulent information is provided.
The Agency, as a Covered Entity under HIPAA, must execute a Business Associate Agreement with MYOUSS Group LLC before submitting any PHI to the platform. Access to platform features that involve PHI will not be enabled until a signed BAA is on file.
The Agency represents and warrants that: (a) it has all necessary authorizations and consents to submit PHI to the platform; (b) it will use the platform's PHI-related features only in accordance with HIPAA and the BAA; and (c) it will not submit PHI in excess of what is necessary for the Services.
HHAOps will handle PHI solely as described in the BAA. In the event of a conflict between these Terms and the BAA with respect to PHI, the BAA controls.
Subscription fees, billing cadence, and payment terms are set forth in the applicable Order Form. Unless otherwise specified in the Order Form, fees are collected via ACH bank transfer and are due on the date specified therein. All fees are non-refundable except as expressly stated in the Order Form or these Terms.
Invoices not paid within thirty (30) days of the due date may result in suspension of the Agency's account. Access will be restored upon payment of all outstanding amounts. We reserve the right to charge interest on overdue amounts at 1.5% per month.
The Agency is responsible for all applicable taxes, levies, or duties imposed by taxing authorities in connection with its Subscription, excluding taxes on our net income.
We may propose changes to Subscription fees upon at least sixty (60) days' written notice. Any fee changes will be reflected in a revised Order Form. Continued use of the Platform after the effective date of a revised Order Form constitutes acceptance of the updated fees.
The Agency and its Users may use the platform only for lawful purposes and in accordance with these Terms. The following are prohibited:
(a) submitting or transmitting any content that violates applicable law; (b) using the platform to store or transmit malware or malicious code; (c) attempting to gain unauthorized access to any part of the platform or its underlying systems; (d) reverse engineering, decompiling, or disassembling any portion of the platform; (e) reselling or sublicensing access to the platform to any third party; (f) using the platform in any manner that could damage, disable, or impair its operation.
The platform, including all software, design, content, trademarks, and documentation, is and remains the exclusive property of MYOUSS Group LLC. These Terms do not grant the Agency any ownership interest in the platform. The Agency receives only a limited, non-exclusive, non-transferable, revocable license to access and use the platform during the Subscription term, solely for its internal operations.
The Agency retains all ownership rights in data it submits to the platform, including PHI and operational data. We claim no ownership over Agency data. The Agency grants us a limited license to process Agency data solely to provide the Services.
If the Agency provides feedback or suggestions regarding the platform, we may use such feedback without restriction or compensation. The Agency hereby assigns to us all rights in such feedback.
Each Party agrees to keep confidential any non-public business, technical, or operational information received from the other Party in connection with these Terms. Neither Party shall disclose such information to third parties without prior written consent, except as required by law. This obligation survives termination for three (3) years. PHI confidentiality is governed exclusively by the BAA.
We represent that the platform will perform materially in accordance with our documentation under normal use.
TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE PLATFORM IS PROVIDED "AS IS" AND "AS AVAILABLE." WE DISCLAIM ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. WE DO NOT WARRANT THAT THE PLATFORM WILL BE UNINTERRUPTED, ERROR-FREE, OR THAT ALL DEFECTS WILL BE CORRECTED.
TO THE MAXIMUM EXTENT PERMITTED BY LAW, IN NO EVENT SHALL MYOUSS GROUP LLC BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING LOST PROFITS OR DATA, ARISING OUT OF OR RELATED TO THESE TERMS OR THE PLATFORM.
Our total aggregate liability to the Agency for any claim arising under these Terms shall not exceed the total fees paid by the Agency in the twelve (12) months preceding the event giving rise to the claim.
The Agency agrees to indemnify, defend, and hold harmless MYOUSS Group LLC and its officers, members, employees, and agents from and against any third-party claims, losses, liabilities, costs, or expenses (including reasonable attorneys' fees) arising out of or related to: (a) the Agency's breach of these Terms or the BAA; (b) the Agency's violation of applicable law, including HIPAA; (c) any claim by a patient, employee, or regulator arising from the Agency's use of the platform; or (d) any unauthorized access to the platform resulting from the Agency's failure to maintain the security of its credentials.
These Terms begin on the date the Agency first accesses the platform and continue for the duration of the Subscription, unless earlier terminated.
Either Party may terminate these Terms immediately upon written notice if the other Party materially breaches these Terms and fails to cure such breach within thirty (30) days of written notice.
Either Party may terminate these Terms upon sixty (60) days' written notice. We may terminate with thirty (30) days' notice if the Agency fails to pay any invoice.
Upon termination: (a) all licenses granted hereunder terminate; (b) the Agency shall cease all use of the platform; (c) we will provide the Agency with a reasonable opportunity to export its non-PHI data; and (d) PHI will be handled as set forth in the BAA. Sections 6, 7, 8, 9, 10, and 13 survive termination.
We reserve the right to modify, update, or discontinue features of the platform at any time, provided we give reasonable notice of material changes. We may update these Terms from time to time and will notify Agencies of material changes at least thirty (30) days in advance. Continued use of the platform after the effective date constitutes acceptance.
These Terms are governed by the laws of the State of New York without regard to conflict of laws principles. Any dispute arising under these Terms shall first be subject to good-faith negotiation for fifteen (15) days, followed by non-binding mediation in New York, NY. Either Party may seek injunctive relief in courts of competent jurisdiction at any time. The Parties consent to the exclusive jurisdiction of the courts of Kings County, New York.
Entire Agreement. These Terms, together with the applicable Order Form and BAA, constitute the entire agreement between the Parties regarding the Platform. In the event of a conflict between these Terms and the Order Form, the Order Form controls solely with respect to the commercial terms it addresses.
Severability. If any provision is found unenforceable, the remaining provisions continue in full force.
Waiver. Failure to enforce any provision shall not constitute a waiver of future enforcement.
Assignment. The Agency may not assign these Terms or any Order Form without our prior written consent. We may assign these Terms in connection with a merger, acquisition, or sale of assets.
Force Majeure. Neither Party shall be liable for delays or failures caused by events beyond its reasonable control.
Notices. Legal notices shall be sent to: MYOUSS Group LLC, 418 Broadway, Suite 11235, Albany, NY 12207, legal@hhaops.com.
For questions about these Terms, please contact:
MYOUSS Group LLC d/b/a HHAOps 418 Broadway, Suite 11235 Albany, NY 12207 Email: legal@hhaops.com Phone: 646-535-3685
© 2026 MYOUSS Group LLC d/b/a HHAOps. All rights reserved.